China's Didi Chuxing raises over US$500m for self-driving unit
[BEIJING] China's Didi Chuxing said on Friday it had completed a fundraising round of over US$500 million for its autonomous driving subsidiary that was led by SoftBank Group's Vision Fund 2.
The ridehailing giant said in a statement the round marked the first time Didi's autonomous driving business had brought in external funding since it became a standalone unit last year.
Didi said it would use the capital to invest further in the research and development of autonomous driving technology as well as testing, and accelerate the deployment of autonomous driving services.
Didi has gained open-road testing licences in California, Beijing, Shanghai and Suzhou, it said. It first began to develop and test autonomous driving vehicles in 2016.
The fundraising comes as SoftBank has been selling off other stakes to raise cash for stock buybacks aimed at supporting the price of its shares as its tech investments falter. Some of the Japanese firm's investments, including Uber and Indian-based hotel chain Oyo, have been hugely impacted by lockdowns in the coronavirus pandemic.
Autonomous driving technology has remained popular with investors even amid the pandemic. Waymo, the self-driving unit of Alphabet this month raised an additional US$750 million in its first external investment round, while China's Pony.ai raised US$462 million from investors led by Toyota Motor in February.
A NEWSLETTER FOR YOU
Garage
The hottest news on all things startup and tech to kickstart your week.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Startups
Semiconductor unicorn Silicon Box vows to avoid geopolitical mire
A cheat sheet of startup and tech M&As in South-east Asia
Zilingo ex-CEO’s criminal complaint is retaliation against whistleblowers: source
Gojek and ComfortDelGro Taxi to send untaken rides to each other’s platforms
SG fintech firm Bambu shuts down after missing profit targets, says founder
Telemedicine platforms evolve beyond virtual consultations